Manfred Dietel To Present on Molecular Pathology at GTC’s Biomarker Europe Summit, Oct. 9-10, Berlin

Berlin, Germany, July 05, 2013 --(PR.com)-- Manfred Dietel, Professor at the Charité – Universitätsmedizin Berlin will give a presentation titled “Predictive Molecular Pathology and the Role of Biomarker Detection” at GTC’s Biomarker Summit Europe 2013 on October 9–10, 2013 in Berlin, Germany.

Dr. Dietel will discuss how molecular pathology has become a major part of tissue based diagnostics and clinical management of infectious diseases and tumors as well as in the development of new anti-cancer drugs. To read a patient’s tissue as “deeply” as possible and to obtain information on morphological, genetic, proteomic as well as epigenetic grounds is both a challenge and an opportunity for modern anatomic pathology.

In his presentation, Dr. Dietel will explain how applications of new techniques play an increasing role in the process of tissue-based diagnostics and in translational cancer research as well as discuss the major challenges, which are:

• To directly detect a broad spectrum of microorganisms
• To precisely and reproducibly diagnose malignant tumors and to establish diagnostic algorithms
• To define the individual prognosis of the actual patient
• To asses the probability of metastases
• To predict response/resistance of individual tumors

GTC’s Biomarker Europe 2013 will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, novel technologies including next-generation sequencing, regulatory and reimbursement issues and companion diagnostics.

For more information, please visit www.gtcbio.com/biomarkerseuro.